Big Gain For RedHill Biopharma Ltd.
Tue, Nov 28, 2023 at 07:35 PM
RedHill Biopharma Ltd. (RDHL:NASDAQ) shot up at $2.28, representing a gain of 128%. On Tue, Nov 28, 2023, RDHL:NASDAQ hit a New 2-Week High of $2.28. The stock appeared on our News Catalysts scanner on Mon, Nov 27, 2023 at 03:17 PM in the 'INVESTOR UPDATE' category. From Tue, Nov 14, 2023, the stock recorded 22.22% Up Days and 30.00% Green Days
About RedHill Biopharma Ltd. (RDHL:NASDAQ)
RedHill Biopharma Ltd is a specialty biopharmaceutical company engaged in the development and commercialization of late clinical-stage, proprietary, and small molecule drugs for the treatment of gastrointestinal and inflammatory diseases and cancer.
Top 10 Gainers:
- SRAX, Inc. (SRAX:NASDAQ), 150%
- RedHill Biopharma Ltd. (RDHL:NASDAQ), 128%
- HNR Acquisition Corp (HNRA:NYSEMKT), 110.41%
- Statera Biopharma Inc. (STAB:NASDAQ), 100%
- IceCure Medical Ltd. (ICCM:NASDAQ), 79.47%
- Kubient Inc. (KBNT:NASDAQ), 55%
- Carbon Revolution Public Limited Company (CREV:NASDAQ), 49.92%
- Scully Royalty Ltd. (SRL:NYSE), 40.19%
- International Tower Hill Mines Ltd. (THM:NYSEMKT), 33.31%
- Conduit Pharmaceuticals Inc Com (CDT:NASDAQ), 31.7%